UCSF's Dr. Mack Roach III to Receive ASTRO Gold Medal for Prostate Cancer Advancements
- Dr. Mack Roach III is awarded ASTRO's Gold Medal for his contributions to radiation oncology, particularly in prostate cancer treatment.
- Roach pioneered the 'Roach Formula' for predicting lymph node involvement and led key Phase III trials using PSA levels for outcome measurement.
- His work includes developing models for predicting survival based on data from prostate cancer patients in Phase III trials.
- Roach's commitment extends to addressing healthcare disparities and serving on the National Cancer Advisory Board.
Mack Roach, III, MD, FASTRO, a radiation oncologist and professor at UCSF, has been selected to receive the American Society for Radiation Oncology (ASTRO) 2024 Gold Medal Award. This honor recognizes Roach's significant contributions to the field, particularly in the treatment and management of prostate cancer.
Roach's research focuses on innovative techniques for prostate cancer treatment, including three-dimensional (3D) conformal radiation therapy and intensity modulated radiation therapy (IMRT). His development of predictive equations, most notably the 'Roach Formula' for estimating the risk of lymph node and seminal vesicle involvement, has significantly impacted patient treatment protocols.
Dr. Roach spearheaded a Phase III trial utilizing prostate-specific antigen (PSA) levels as a measure for outcomes, incorporating PSA nadir as a secondary endpoint. He also developed a model to predict disease-specific and overall survival based on data from prostate cancer patients treated in Phase III trials.
"This award is an incredible honor and I thank ASTRO for recognizing the work I have been involved with in treatment, research and heath equity," said Roach. "I also want to thank my colleagues and my inspiring patients who provide the strongest motivation for advancing our field."
Roach's commitment to community service includes over two decades of volunteer work in cancer control and reducing healthcare disparities. He served on the National Cancer Advisory Board (NCAB) and received an honorary doctorate from Morehouse College.
Dr. Roach has been a UCSF faculty member since 1990 and chaired the Department of Radiation Oncology from 2006 to 2015. He holds a medical degree from Stanford University School of Medicine and completed fellowships and residencies at multiple institutions.
Roach is a member of several professional organizations, including the American Society of Clinical Oncology and the American Cancer Society. The ASTRO Gold Medal will be presented at ASTRO’s 66th Annual Meeting in Washington, DC.

Stay Updated with Our Daily Newsletter
Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.
Related Topics
Reference News
[1]
UCSF Radiation Oncologist Honored for Prostate Cancer Care and Research - Newswise
newswise.com · Sep 30, 2024
Mack Roach, III, MD, FASTRO, receives ASTRO's 2024 Gold Medal Award for significant contributions to radiation oncology,...